CorVel Corporation

NASDAQ:CRVL

Insurance - Brokers

Financial Services
$88.87 -0.12%

-$0.07 today

Market cap
$4.47B
Beta
0.98
P/E (TTM)
26.9
EPS (TTM)
$2.16
52W Low $44.83High $105.51

Volume 0.26M

Average 0.22M

CRVL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

CorVel CorporationNASDAQ: CRVL

Weighted Avg Shares (Diluted) · Q2 FY2027 · quarter ended Sep 2026

Weighted avg shares (diluted) declines year over year

Q2 FY2027 weighted avg shares (diluted) of 50.69M shares fell 2.0% year over year, in line with the -1.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.5% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.

Context

  • Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -2.0% toward the trailing-twelve-month pace of -1.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
50.69M-0.5% QoQ
Last fiscal yearMar 2026
51.63M-0.8% YoY
LTMSep 2026
51.12M-1.6% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.0%——
1 year-0.8%——
3-year CAGR-0.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2026
51.63M USD
Year-over-year change
-0.8%
4-year CAGR
-1.3%

Weighted Avg Shares (Diluted) vs competitors

How CRVL compares with its peers on the latest reported figures

  • CRVL's LTM Sep 2026 weighted avg shares (diluted) of 51.12M shares is the 3rd highest of the 4 companies compared; the peer median is 85.87M shares.
  • Its year-over-year change of -1.6% is the 3rd highest of 4, against a peer median of -0.8%.
  • Over three fiscal years its annual growth of -0.7% compares with a peer median of +1.2%.
CRVL Competitors Peer median
Weighted Avg Shares (Diluted) for CRVL and competitors
Company Period LTM YoY 3-year CAGR
EVHEvolent Health, Inc.LTM Mar 2026114.02M -0.8%+6.8%
HQYHealthEquity, Inc.LTM Jul 202685.87M -2.8%+1.2%
CRVLCorVel CorporationLTM Sep 202651.12M -1.6%-0.7%
CTEVClaritev CorporationLTM Mar 202616.52M +2.1%+1.0%
Peer median (excluding CRVL) 85.87M-0.8%+1.2%

Competitors are the stored peer set for CRVL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue646.23M718.56M795.31M895.59M958.53M
Cost of Revenue494.12M560.3M623.62M685.86M725.66M
Gross Profit152.11M158.26M171.69M209.73M232.86M
Gross Margin23.5%22.0%21.6%23.4%24.3%
Research & Development00000
Selling, General & Admin67.6M73.71M76.59M88.9M89.73B
Operating Expenses67.6M73.71M76.59M88.9M89.73M
Depreciation & Amortization23.92M25.12M26.25M29.54M31.76M
EBITDA108.43M109.68M121.35M150.36M174.9M
EBITDA Margin16.8%15.3%15.3%16.8%18.2%
Operating Income84.51M84.55M95.1M120.82M143.13M
Operating Margin13.1%11.8%12.0%13.5%14.9%
Interest Income00000
Interest Expense00000
Other Income / Expenses00000
Income Before Tax84.51M84.55M95.1M120.82M143.13M
Pre-Tax Margin13.1%11.8%12.0%13.5%14.9%
Income Tax Expense18.1M18.19M18.85M25.66M32.79M
Net Income66.41M66.37M76.25M95.17M110.34M
Net Margin10.3%9.2%9.6%10.6%11.5%
EPS (Basic)1.251.281.481.852.15
EPS (Diluted)1.221.261.471.832.14
Weighted Avg Shares53.26M51.98M51.37M51.39M51.28M
Weighted Avg Shares (Diluted)54.38M52.78M52.04M52.04M51.63M

CorVel Corporation

NASDAQ:CRVL

Intrinsic Alpha fair value

Locked

Current Price

$88.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.